Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Latest filing published 04 Feb 2026 for Fulcrum Therapeutics, Inc., €139k. Read the official filing
Filing timeline
BuySaleRobert J. Gould
Insider track record
Disclosed buys
0
Disclosed sells
5
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Robert J. Gould: trading record in brief
Robert J. Gould is a declared insider of Fulcrum Therapeutics, Inc. (senior executive), with filings sourced from SEC (Form 4). In total, 9 filings cover trades dated from 1 April 2022 to 2 February 2026.
Sales make up the whole of the open-market record (5 sales, €662k). Besides market trades, the filings include 4 option exercises. In 2026 alone, the filings show no purchases and 3 sales.
The newest entry dates from 4 February 2026: an open-market sale of €139k, in Fulcrum Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Robert J. Gould
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
15,000 shares@ US$10.87260.031% mcap7.8% of flowCommon StockSEC:0001193125-26-037606:0
15,000 shares@ US$10.72380.030% mcap7.6% of flowCommon StockSEC:0001193125-26-037573:0
15,000 shares@ US$11.87260.034% mcap8.5% of flowCommon StockSEC:0001193125-26-004572:0
15,000 shares@ US$11.0339.0% of flowCommon StockSEC:0001193125-25-291392:0
6,766 shares@ US$15.005.0% of flowCommon StockSEC:0000899243-23-001803:0
71,435 shares@ US$7.840.12% mcap29.4% of flowCommon StockSEC:0000899243-22-021530:0
16,689 shares@ US$7.840.027% mcap6.8% of flowCommon StockSEC:0000899243-22-021250:0
5,631 shares@ US$7.840.0091% mcap2.3% of flowCommon StockSEC:0000899243-22-014438:0
34,464 shares@ US$7.840.055% mcap13.7% of flowCommon StockSEC:0000899243-22-013881:0
9 of 9 declarations
